Proteomic analysis of human ovarian cancer paclitaxel-resistant cell lines

Journal of Central South University (Medical Sciences)

Volumn 35, Issue 4, 2010, Pages 286-294

  Cao, Lanqin ^a   Li, Xin ^a   Zhang, Yi ^a   Peng, Fang ^b   Yi, Hong ^b   Xu, Yan ^b   Li, Xinguo ^a   Wang, Qian ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Drug resistance; Human ovarian cancer cell; Paclitaxel; Proteomics

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLINE; NME1 PROTEIN, HUMAN; NUCLEOSIDE DIPHOSPHATE KINASE NM23; PACLITAXEL; PROHIBITIN; PROTEOME; REPRESSOR PROTEIN;

ARTICLE; DRUG RESISTANCE; FEMALE; GENETICS; HUMAN; METABOLISM; METHODOLOGY; OVARY TUMOR; PATHOLOGY; PROTEOMICS; TUMOR CELL LINE; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL LINE, TUMOR; DRUG RESISTANCE, NEOPLASM; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; HUMANS; NM23 NUCLEOSIDE DIPHOSPHATE KINASES; OVARIAN NEOPLASMS; PACLITAXEL; PROLIFERATING CELL NUCLEAR ANTIGEN; PROTEOME; PROTEOMICS; REPRESSOR PROTEINS;

EID: 77952866983     PISSN: 16727347     EISSN: None     Source Type: Journal    
DOI: 10.3969/j.issn.1672-7347.2010.04.002     Document Type: Article

References (13)

1. YAN Xuedong, LI Min, ZHANG Mingwei, et al. Characterization of taxol - resistance ovarian cancer cell lines induced by different administrations approaches [J]. Basic And Clinical Medicine, 2006, 26(3):284-289.
2. Gobom J, Schuerenberg M, Mueller M, et al. Alpha - cyano-4- hydroxycinnamic acid affinity sample preparation. A protocol for MALDI - MS peptide analysis in proteomics [J]. Anal Chem, 2001, 73(3):434-438.
3. Cicchillitti L, Di Michele M, Urbani A, et al. Comparative proteomics analysis of paclitaxel sensitive A27 80 epithelial ovarian cancer cell line and its resistant counterpart A2780 TG by 2D-DIGE: the role of ERP57 [J]. J Proteome Res, 2009, 8(4):1902-1912.
4. ZHANG Wenjing, LI Hongxia, SONG Lei, et al. Screening differential expression of taxol - resistence related gene of ovarian carcinoma by cDNA microarray [J]. Cancer Prevention Research, 2006, 33(1):32-35.
5. ZHANG Wenjing, Dong Xiaolin, LI Hongxia. Gene differential expression in ovarian cancer taxol - resistant SKOV3/TAX cell line[J]. Shandong Medicine, 2009, 49(26):3-4.
6. Le Moguen K, Lincet H, Deslandes E, et al. Comparative proteomic analysis of cisplatin sensitive IGROV1 ovarian carcinoma cell line and its resistant counterpart IGROV1 - R10 [J]. Proteomics, 2006, 6(19):5183-5192.
7. Reitmaier M, Rudlowski C, Biesterfeld S, et al. Comparative stuies on the biological significance of the marker for proliferation ki-67-antigen and PCNA in primary ovarian carcinoma [J]. Zentralbl Gynakol, 2000, 122(3):361-367.
8. HE Yinfang, WU Zhiyu, HAN Qingwei. Expression and significance of PTEN and PCNA in ovarian epithelial carcinoma [J]. J Fourth Mil Med Univ, 2005, 26(19):1808-1810.
9. Steeg P S, Bevilacqua G, Kopper L, et al. Evidence for a novel gene associated with low tumor metastatic potential [J]. J Natl Cancer Inst, 1988, 80(3):200-204.
10. WANG Huixiang. Expression and significance of E-cadherin and nm23 in ovarian epithelial carcinoma [J]. Shandong Medicine, 2007, 47(20):30-31.
11. Fusaro G, Wang S, Chellappan S. Differential regulation of Rb family proteins and prohibitin during camptothecin - induced apoptosis [J]. Oncogene, 2002, 21(29):4539-4548.
12. Rqviezzo F, Getting S J, Paul-Clark M J, et al. The annexin-1 knockout mouse: what it tells us about the inflammatory response [J]. J Physiol Pharmacol, 2002, 53(4):541-553.
13. Ariazi E A, Satomi Y, Ellis M J, et al. Activation of the transforming growth factor beta signaling pathway and induction of cytostasis and apoptosis in mammary carcinomas treated with the anticancer agent perillyl alcohol [J]. Cancer Res, 1999, 59(8):1917-1928.